5264 articles
Scott Megaffin, CEO of Adastra Pharmaceuticals, Inc., a company focused on the treatment of cancers with high unmet needs (such as high-grade gliomas), ...
Astellas Oncology has announced the three finalists for the 2020 C3 Prize (Changing Cancer Care). One of the finalists, Lisa McKenzie is here to share...
at ViiV Healthcare, discusses a recent report released by ViiV Healthcare called “Tal Como Soy/Here as I Am” which analyzed multiple factors that co...
Returning guest and study author, Steve Shak, Chief Medical Officer at Exact Sciences discusses results presented at SABCS (San Antonio Breast Cancer Sy...
John Huemoeller, CEO of AXIM Biotechnologies, an international healthcare solutions company based in San Diego targeting oncological and COVID-19 resear...
Dave Marver, CEO of ONWARD, discusses the work they are doing with both non-invasive and implantable neuromodulation technologies to improve the quality...
Paul Brennan, President and CEO of NervGen Pharma Corp, developer of treatments related to nerve damage and neurodegenerative diseases, discusses the st...
Steven Engle, CEO of CohBar, Inc, a clinical stage biotechnology company discusses his article in "Grit Daily" (Jan 8, 2021) on NASA's breakthrough stud...
Mike, a clinical psychologist discusses the podcast he is hosting called "Going There". Learn more on Health Professional Radio.
Tania Gonzalez-Rivera, MD, BENLYSTA Global Medical Affairs Lead at GlaxoSmithKline (GSK) discusses the recent FDA approval of BENLYSTA (Belimumab) the f...